Puma Biotechnology Inc. (NYSE:PBYI)

CAPS Rating: 1 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar 1russianguy (87.57) Submitted: 8/20/2015 3:29:53 PM : Outperform Start Price: $88.32 PBYI Score: +6.15

Playing for a bounce from a correction.

Recs

0
Member Avatar clangmead (30.51) Submitted: 8/6/2015 6:18:15 AM : Outperform Start Price: $90.00 PBYI Score: +8.20

mpor1

Recs

0
Member Avatar TMFTypeoh (83.62) Submitted: 6/24/2015 11:57:47 AM : Outperform Start Price: $124.55 PBYI Score: -19.72

Pullback could be a decent entry point. Strong inside ownership.

Recs

0
Member Avatar CramersSkeeDaddy (97.70) Submitted: 7/23/2014 2:04:00 PM : Underperform Start Price: $232.10 PBYI Score: +59.82

up 300% in one day, enough said. Hopefully they do cure/treat all cancer but the short squeeze will likely end soon. No or little revenue, or earnings.

Recs

0
Member Avatar dabhsar (< 20) Submitted: 6/2/2013 8:56:29 AM : Outperform Start Price: $39.55 PBYI Score: +111.84

This small Bio Tech company is onto key medicine break through.

Recs

0
Member Avatar IBDContrarian (24.24) Submitted: 4/6/2013 1:50:39 PM : Underperform Start Price: $30.95 PBYI Score: -169.77

IBD EPS, RS, SPROE, Acc ratings plus P/E and div yield
MEDICAL 1 96 -- A- NO EARN

Results 1 - 6 of 6

Featured Broker Partners


Advertisement